Shares of Jaguar Health Inc (NASDAQ:JAGX) saw an uptick in trading volume on Wednesday . 1,591,549 shares traded hands during trading, an increase of 613% from the previous session’s volume of 223,146 shares.The stock last traded at $2.79 and had previously closed at $2.70.

Several analysts have recently issued reports on JAGX shares. ValuEngine lowered shares of Zumiez from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd. HC Wainwright set a $10.00 target price on shares of Jaguar Health and gave the stock a “buy” rating in a research note on Tuesday, July 2nd. Finally, Zacks Investment Research upgraded shares of Booz Allen Hamilton from a “hold” rating to a “buy” rating and set a $71.00 target price for the company in a research note on Friday, June 28th.

The company has a current ratio of 0.30, a quick ratio of 0.18 and a debt-to-equity ratio of 0.02. The stock has a market cap of $4.04 million, a PE ratio of -0.02 and a beta of 0.70. The company has a 50 day simple moving average of $4.13.

Jaguar Health (NASDAQ:JAGX) last posted its earnings results on Tuesday, May 21st. The biotechnology company reported ($12.59) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($13.29) by $0.70. Jaguar Health had a negative net margin of 667.59% and a negative return on equity of 372.84%. The firm had revenue of $1.59 million during the quarter, compared to analyst estimates of $2.20 million. As a group, sell-side analysts anticipate that Jaguar Health Inc will post -6.07 earnings per share for the current year.

Jaguar Health Company Profile (NASDAQ:JAGX)

Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Recommended Story: Futures Contract

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.